RYBREVANT 3520mg solution for injection CILAG
amivantamab Indicated for: non-small cell lung cancer
letter R · page 60
amivantamab Indicated for: non-small cell lung cancer
midostaurin Indicated for: acute myeloid leukemia; systemic mastocytosis
relugolix + estradiol + norethisterone Indicated for: menopausal symptoms
human alfa-1 proteinase inhibitor Indicated for: alpha-1 antitrypsin deficiency
B02AB02 Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors
human alfa-1 proteinase inhibitor Indicated for: alpha-1 antitrypsin deficiency
B02AB02 Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors
rozanolixizumab Indicated for: myasthenia gravis
propafenone Indicated for: cardiac arrhythmias
C01BC03 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic
propafenone Indicated for: cardiac arrhythmias
C01BC03 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic
insulin degludec + insulin aspart Indicated for: diabetes mellitus
insulin degludec + insulin aspart Indicated for: diabetes mellitus